Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with 
brain atrophy in early multiple sclerosis

Graetz, Christiane; Groeger, Adriane; Luessi, Felix; Salmen, Anke; Zoeller, Daniela; Schultz, Janine; Siller, Nelly; Fleischer, Vinzenz; Bellenberg, Barbara; Berthele, Achim; Biberacher, Viola; Havla, Joachim; Hecker, Michael; Hohlfeld, Reinhard; Infante-Duarte, Carmen; Kirschke, Jan S.; Kuempfel, Tania; Linker, Ralf; Paul, Friedemann; Pfeuffer, Steffen; Saemann, Philipp; Toenges, Gerrit; Weber, Frank; Zettl, Uwe K.; Jahn-Eimermacher, Antje; Antony, Gisela; Groppa, Sergiu; Wiendl, Heinz; Hemmer, Bernhard; Muehlau, Mark; Lukas, Carsten; Gold, Ralf; Lill, Christina M.; Zipp, Frauke

doi:10.1177/1352458518763541

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Previous Next of 11462

Released

Journal Article

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis

MPS-Authors

Saemann, Philipp
Max Planck Institute of Psychiatry, Max Planck Society;

Weber, Frank
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Graetz, C., Groeger, A., Luessi, F., Salmen, A., Zoeller, D., Schultz, J., et al. (2019). Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis. Multiple Sclerosis Journal, 25(5), 661-668. doi:10.1177/1352458518763541.

Cite as: https://hdl.handle.net/21.11116/0000-0006-47C6-B

Abstract

Background: The course of multiple sclerosis (MS) shows substantial inter-individual variability. The underlying determinants of disease severity likely involve genetic and environmental factors. Objective: The aim of this study was to assess the impact of APOE and HLA polymorphisms as well as smoking and body mass index (BMI) in the very early MS course. Methods: Untreated patients (n = 263) with a recent diagnosis of relapsing-remitting (RR) MS or clinically isolated syndrome underwent standardized magnetic resonance imaging (MRI). Genotyping was performed for single-nucleotide polymorphisms (SNPs) rs3135388 tagging the HLA-DRB1*15:01 haplotype and rs7412 (190;2) and rs429358 (190;4) in APOE. Linear regression analyses were applied based on the three SNPs, smoking and BMI as exposures and MRI surrogate markers for disease severity as outcomes. Results: Current smoking was associated with reduced gray matter fraction, lower brain parenchymal fraction and increased cerebrospinal fluid fraction in comparison to non-smoking, whereas no effect was observed on white matter fraction. BMI and the SNPs in HLA and APOE were not associated with structural MRI parameters. Conclusions: Smoking may have an unfavorable effect on the gray matter fraction as a potential measure of MS severity already in early MS. These findings may impact patients' counseling upon initial diagnosis of MS.